Sleep program aims to reduce pregnancy risks in african american women

NCT ID NCT05234125

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests a culturally tailored sleep program called Sleep BETTER for African American pregnant women who are overweight or obese. The program combines sleep hygiene tips and cognitive-behavioral techniques to help improve glucose metabolism and reduce pregnancy complications. Participants are randomly assigned to either the sleep program or a standard pregnancy education group, and their blood sugar and insulin levels are tracked.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Sleep BETTER behavioral sleep intervention
What this could lead to
If effective, this program could offer a simple, non-drug way to improve metabolic health and reduce pregnancy complications in African American women.
What could go wrong
This is a small, early-stage trial. The intervention may not significantly improve glucose levels, and results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AFRICAN AMERICANS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity Obesity obesity disorder Overweight Parasomnias pregnancy disorder sleep disorder Sleep Hygiene Stress, Psychological

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Illinois at Chicago

    RECRUITING

    Chicago, Illinois, 606012, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Illinois at Chicago

    RECRUITING

    Chicago, Illinois, 60612, United States

    Contact Phone: •••-•••-••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.